Article

You have full text access to this OnlineOpen article

The burden of hepatitis C in the United States

  1. W. Ray Kim*

Article first published online: 10 FEB 2006

DOI: 10.1002/hep.1840360705

Issue

Hepatology

Hepatology

Supplement: National Institutes of Health Consensus Development Conference

Volume 36, Issue Supplement 1, pages S30–S34, November 2002

Additional Information

How to Cite

Kim, W. R. (2002), The burden of hepatitis C in the United States. Hepatology, 36: S30–S34. doi: 10.1002/hep.1840360705

Author Information

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN

*W. Ray Kim, M.D., Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN. 507–266–2810

Publication History

  1. Issue published online: 10 FEB 2006
  2. Article first published online: 10 FEB 2006

Funded by

  • National Institute of Diabetes and Digestive and Kidney Diseases. Grant Number: R01-DK-34238

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (552K)

References

  • 1
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556–562.
  • 2
    Center for Disease Control and Prevention. Hepatitis C virus infection among firefighters, emergency medical technicians, and paramedics. Selected locations, United States, 1991 –2000. MMWR Morbid Mortal Wkly Rep 2000; 49: 660–665.
  • 3
    Briggs M, Baker C, Hall R, Gaziano J, Gagnon D, Bzowej N, Wright T. Prevalence and risk factors for hepatitis C virus infection at an urban veterans administration medical center. Hepatology 2001; 34: 1200–1205.
    Direct Link:
  • 4
    Cheung R, Hanson A, Maganti K, Keeffe E. Matsui S. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol 2002; 34: 476–480.
  • 5
    Ruiz JD, Molitor F, Sun RK, Mikanda J, Facer M, Colford JM Jr., Rutherford GW, et al. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med 1999; 170: 156–160.
  • 6
    Reindollar RW. Hepatitis C and the correctional population. Am J Med 1999; 107: 100–103.
  • 7
    Center for Disease Control and Prevention (CDC). Recommendations for prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR Morbid Mortal Wkly Rep 1998; 47: 1–9.
  • 8
    Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107: 2S–9S.
  • 9
    Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284: 229–235.
  • 10
    Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777–782.
    Direct Link:
  • 11
    Centers for Disease Control and Prevention. Compressed Mortality File. Available at: http://wonder.cdc.gov. (accessed March 10, 2002).
  • 12
    Kim W, Gross J, Poterucha J, Locke G, Dickson E. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology 2001; 33: 201–206.
    Direct Link:
  • 13
    Bonkovsky HL, Woolley JM, for the Consensus Interferon Study Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999; 29: 264–270.
    Direct Link:
  • 14
    Ware JE Jr., Bayliss MS, Mannocchia M, Davis GL, for the Interventional Therapy Group. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Hepatology 1999; 30: 550–555.
    Direct Link:
  • 15
    McHutchison JG, Ware JE Jr., Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001; 34: 140–147.
  • 16
    Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 2737–2744.
    Direct Link:
  • 17
    Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30: 299–301.
    Direct Link:
  • 18
    Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500–1511.
Get PDF (552K)